Patents by Inventor Jujun Wang

Jujun Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL CLASS OF QUINOLONE HETEROCYCLIC AROMATIC MOLECULES FOR CANCER TREATMENT
    Publication number: 20190169134
    Abstract: The invention is directed to new class of quinolone heterocyclic aromatic molecules (Renotinibs) and their use in the treatment of cancer, in particular, cancer that harbor abnormal human epidermal growth factor receptors (EGFRs) and or cancer that has abnormal DNA repair system.
    Type: Application
    Filed: February 11, 2019
    Publication date: June 6, 2019
    Inventors: Jujun Wang, Allen Tsao
  • Class of quinolone heterocyclic aromatic molecules for cancer treatment
    Patent number: 10202357
    Abstract: The invention is directed to new class of quinolone heterocyclic aromatic molecules (Renotinibs) and their use in the treatment of cancer, in particular, cancer that harbor abnormal human epidermal growth factor receptors (EGFRs).
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: February 12, 2019
    Assignee: RenoTarget Therapeutics, Inc.
    Inventors: Jujun Wang, Allen Tsao, Xiaomei Liu
  • NOVEL CLASS OF QUINOLONE HETEROCYCLIC AROMATIC MOLECULES FOR CANCER TREATMENT
    Publication number: 20180127383
    Abstract: The invention is directed to new class of quinolone heterocyclic aromatic molecules (Renotinibs) and their use in the treatment of cancer, in particular, cancer that harbor abnormal human epidermal growth factor receptors (EGFRs).
    Type: Application
    Filed: November 3, 2017
    Publication date: May 10, 2018
    Inventors: Jujun Wang, Allen Tsao, Xiaomei Liu